Claire Spofford - Mar 29, 2025 Form 4 Insider Report for J.Jill, Inc. (JILL)

Role
President & CEO, Director
Signature
/s/ Kathleen Stevens, Attorney-in-Fact
Stock symbol
JILL
Transactions as of
Mar 29, 2025
Transactions value $
-$233,233
Form type
4
Date filed
4/2/2025, 06:47 PM
Previous filing
Mar 13, 2025
Next filing
Apr 15, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JILL Common Stock Options Exercise +5.85K +4.05% 150K Mar 29, 2025 Direct F1
transaction JILL Common Stock Tax liability -$53.3K -2.85K -1.9% $18.69 147K Mar 29, 2025 Direct F2
transaction JILL Common Stock Options Exercise +19.8K +13.4% 167K Mar 31, 2025 Direct F3
transaction JILL Common Stock Tax liability -$180K -9.63K -5.76% $18.69 158K Mar 31, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JILL Restricted Stock Units Options Exercise $0 -5.85K -50% $0.00 5.85K Mar 29, 2025 Common Stock 5.85K Direct F1, F4
transaction JILL Restricted Stock Units Options Exercise $0 -19.8K -100% $0.00 0 Mar 31, 2025 Common Stock 19.8K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 5,854 restricted stock units ("RSUs") held by Ms. Spofford vested on March 29, 2025, and were settled in exchange for a like amount of shares of common stock, par value $0.01 per share ("Common Stock") of J.Jill, Inc.
F2 Shares reported were withheld from Ms. Spofford for the payment of taxes associated with the vesting of previously granted RSUs.
F3 19,762 RSUs held by Ms. Spofford vested on March 31, 2025, and were settled in exchange for a like amount of shares of Common Stock of J.Jill, Inc.
F4 Each RSU represents a contingent right to receive one share of Common Stock of J.Jill, Inc.